Table 2.

Incidence of clinical outcomes by baseline category of kidney function and diabetic statusa

No CKD NondiabeticCKD NondiabeticNo CKD DiabeticCKD Diabetic
N14,1944099873571
Outcome Events (rate [95% CI])
    coronary heart disease death, nonfatal MI, CABG, or PTCA15.2 (14.6 to 15.8)18.6 (17.6 to 19.8)21.3 (19.2 to 23.7)27.0 (24.1 to 30.1)
    coronary heart disease death, nonfatal myocardial infarction, CABG, PTCA, or stroke16.7 (16.1 to 17.4)21.2 (20.1 to 22.4)25.2 (22.9 to 27.7)31.7 (28.7 to 34.9)
    all-cause mortality6.4 (6.0 to 6.8)10.3 (9.4 to 11.2)11.6 (9.9 to 13.6)18.5 (15.9 to 21.6)
    coronary heart disease death or nonfatal MI8.9 (8.5 to 9.5)13.3 (12.3 to 14.3)14.8 (12.7 to 17.1)20.1 (18.1 to 24.3)
    CABG or PTCA7.4 (6.9 to 7.9)7.5 (6.8 to 8.2)8.6 (7.3 to 10.1)10.0 (8.4 to 12.0)
    any stroke2.2 (1.9 to 2.4)3.6 (3.0 to 4.2)5.8 (4.5 to 7.4)7.5 (5.7 to 9.9)
  • a Median follow-up period was 64 mo. CI, confidence interval; CAD, coronary artery disease; CABG, coronary artery bypass graft surgery; PTCA, percutaneous coronary angiography. %, adjusted for treatment assignment and trial (CARE, LIPID, or WOSCOPS). Parentheses contain 95% CI.